Dallah Healthcare Company
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Saudi Arabia.
P/E ratio
16.6Investors pay 16.6 for every 1 of Dallah Healthcare Company's yearly profit, higher than 71% of Healthcare companies in Saudi Arabia.
P/B ratio
1.77The share price is 1.77 times Dallah Healthcare Company's book value per share, lower than 71% of Healthcare companies in Saudi Arabia.
Market cap
SAR 7.3 BThe total market value of all of Dallah Healthcare Company's shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in Saudi Arabia. PosiCap size class: Meso Cap.
Return on equity (ROE)
10.3%Dallah Healthcare Company earned 10.3% on its shareholders' money over the last year, lower than 86% of Healthcare companies in Saudi Arabia.
Dividend yield
2.62%Dallah Healthcare Company pays 2.62% of its share price as dividends a year, lower than 62% of dividend-paying Healthcare companies in Saudi Arabia.
Questions
What is Dallah Healthcare Company's P/E ratio?
Investors pay 16.6 for every 1 of Dallah Healthcare Company's yearly profit, higher than 71% of Healthcare companies in Saudi Arabia.
What is Dallah Healthcare Company's return on equity?
Dallah Healthcare Company earned 10.3% on its shareholders' money over the last year, lower than 86% of Healthcare companies in Saudi Arabia.
Does Dallah Healthcare Company pay a dividend?
Yes. Dallah Healthcare Company pays 2.62% of its share price as dividends a year, lower than 62% of dividend-paying Healthcare companies in Saudi Arabia.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.